3 weeks ago

IIT Bombay Study Reveals Why Deadly Brain Cancer Returns

IIT Bombay Study Reveals Why Deadly Brain Cancer Returns
IIT Bombay Study Reveals Why Deadly Brain Cancer Returns After Treatment · freepressjournal.in

A very dangerous brain cancer called glioblastoma usually comes back after treatment, and when it returns it is even harder to treat.

Scientists at IIT Bombay wanted to find out why this happens.

They discovered that the softness of the brain matters a lot for how the cancer behaves.

For a long time, scientists studied cancer cells on hard plastic dishes, which does not match the real brain.

On those hard dishes, returning cancer cells looked the same as the first cancer cells, so scientists could not see what made them different.

But when the same cells were grown on soft gels that feel like brain tissue, they became more aggressive and moved around more, just like in patients.

The scientists also found a special protein called PLEKHA7 that only showed up when cells grew on soft gels and was higher in patients whose cancer had returned.

When they blocked this protein, the tumours grew and spread much less.

They also found that a molecule called NEAT1 helped cancer act more aggressively in a soft brain-like environment, and lowering its levels slowed the cancer.

This shows that testing cancer drugs in brain-like soft gels could help scientists create better treatments.

Key facts

Cancer type
Glioblastoma
Lead researcher
Prof. Abhijit Majumder, IIT Bombay
Collaborating institution
ACTREC, Tata Memorial Centre
Study journal
Matrix Biology
Key finding
Brain tissue softness drives aggressiveness of recurrent tumours
Biomarkers identified
Protein PLEKHA7 and RNA molecule NEAT1
Patient survival after diagnosis
Six months to one year
Cancer drug failure rate in clinical trials
Nearly 90%

Quotes

Prof. Abhijit Majumder

Lead investigator of the IIT Bombay glioblastoma study

“The rigid surface didn't just suppress the cells' aggressive behaviour; it completely erased the distinction between primary and recurrent tumour cells.”
freepressjournal.in
“If someone has a cancer drug target, they should include soft gels and tumoroids as an initial experiment.”
freepressjournal.in

Sources

Related news